Vitamin D for cancer prevention: global perspective.
Garland CF, Gorham ED, Mohr SB, Garland FC.
Ann Epidemiol. 2009 Jul;19(7):468-83. Review.
PMID: 19523595
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M.
Cancer Res. 2004 Aug 15;64(16):5617-23.
PMID: 15313899
Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.
Scheckel KA, Degner SC, Romagnolo DF.
J Nutr. 2008 Nov;138(11):2098-105.
PMID: 18936204
Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.
Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G.
Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5. Epub 2005 Jan 19.
PMID: 15774240
doi:10.1016/j.eururo.2004.12.001
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.
Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C
Int J Cancer. 2008 Sep 15;123(6):1227-39. Review.
PMID: 18623084
Cannabinoids and cancer: causation, remediation, and palliation.
Hall W, Christie M, Currow D.
Lancet Oncol. 2005 Jan;6(1):35-42. Review.
PMID: 15629274
doi:10.1016/S1470-2045(04)01711-5
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M.
Cancer Res. 2008 Mar 15;68(6):1945-52.
PMID: 18339876
doi: 10.1158/0008-5472.CAN-07-5176
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M.
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31.
PMID: 19285265
doi:10.1016/j.beem.2009.02.001
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.
Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, Latino-Martel P.
Lancet Oncol. 2009 Feb;10(2):173-80. Review.
PMID: 19185835
doi:10.1016/S1470-2045(09)70019-
Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach.
Boccia S, Hashibe M, Gallì P, De Feo E, Asakage T, Hashimoto T, Hiraki A, Katoh T, Nomura T, Yokoyama A, van Duijn CM, Ricciardi G, Boffetta P.
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):248-54.
PMID: 19124505
doi: 10.1158/1055-9965.EPI-08-0462
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity.
Lachenmeier DW.
J Occup Med Toxicol. 2008 Nov 13;3:26.
PMID: 19014531
doi:10.1186/1745-6673-3-26
Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.
Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN.
J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. English, German.
PMID: 19138272
DOI: 10.1111/j.1610-0387.2008.06861.x
Structure-function relationships of anthocyanins from various anthocyanin-rich extracts on the inhibition of colon cancer cell growth.
Jing P, Bomser JA, Schwartz SJ, He J, Magnuson BA, Giusti MM.
J Agric Food Chem. 2008 Oct 22;56(20):9391-8. Epub 2008 Sep 19.
PMID: 18800807
DOI: 10.1021/jf8005917
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
Clin Cancer Res. 2004 Sep 1;10(17):5930-9.
PMID: 15355926
Group items tagged 
Cached
